Besides, administration of 1-Kestose was found to significantly increase the population of CD4+Foxp3+ cells in mesenteric lymph nodes (MLNs) (44), suggesting that 1-kestose might suppress inflammation-induced CRC by regulating intestinal immunity (Supplementary Figure 4). Here, CD4 is linked to colorectal carcinoma.